FDA Licensed Ebola Virus Therapeutics BARDA-CBRN-022026

Solicitation BARDA-CBRN-022026 Copied Notice ID dd9fd0d7418d4f458170842f3423dbd6 Copied HEALTH AND HUMAN SERVICES, DEPARTMENT OF — BARDA - ASPR / DAAPPO / BARDA DCMA

SAM.gov

Posted

Feb 20, 2026

Deadline

Mar 13, 2026

Set-aside

NONE

NAICS

N/A

PSC

6505

Summary

AI-generated · Feb 21, 2026

Feedback from current and potential biopharmaceutical partners regarding FDA-licensed Ebola virus therapeutics will inform continued market research for possible future acquisitions and programs.

This Sources Sought activity is intended to collect industry input to help shape potential future opportunities and program development.

The Biomedical Advanced Research and Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR) at the United States (U.S.) Department of Health and Human Services (HHS), is issuing this SSN to collect feedback from current and potential biopharmaceutical partners. Information collected from this SSN will serve as continued market research for possible future acquisitions and programs.

From Sources Sought posted on Feb 20, 2026

Notice history

Sources Sought LATEST Posted Feb 20, 2026 View

Details

Solicitation number BARDA-CBRN-022026

Notice ID dd9fd0d7418d4f458170842f3423dbd6

Notice type Sources Sought

Product / Service (PSC) 6505

Set-aside No Set aside used

Place of performance USA

Archive date Mar 28, 2026

Award Information

Not yet awarded

Documents

Document 1

Contacts

primary

Yifan Yang

secondary

Justin Moore

Agency

HEALTH AND HUMAN SERVICES, DEPARTMENT OF

OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE

BARDA - ASPR / DAAPPO / BARDA DCMA

Place of Performance

USA

Dates

Posted Feb 20, 2026 5 months ago

Last Updated Aug 06, 2026 1 day ago

Due Mar 13, 2026 4 months ago